WO2010057264A1 - Analyte detection assay - Google Patents
Analyte detection assay Download PDFInfo
- Publication number
- WO2010057264A1 WO2010057264A1 PCT/AU2009/001515 AU2009001515W WO2010057264A1 WO 2010057264 A1 WO2010057264 A1 WO 2010057264A1 AU 2009001515 W AU2009001515 W AU 2009001515W WO 2010057264 A1 WO2010057264 A1 WO 2010057264A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particles
- wgm
- analyte
- particle
- microspheroidal
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 119
- 238000003556 assay Methods 0.000 title claims abstract description 88
- 238000001514 detection method Methods 0.000 title claims abstract description 83
- 239000002245 particle Substances 0.000 claims abstract description 407
- 229920000877 Melamine resin Polymers 0.000 claims abstract description 96
- 239000003446 ligand Substances 0.000 claims abstract description 95
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 claims abstract description 80
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 26
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 25
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 25
- 239000002096 quantum dot Substances 0.000 claims abstract description 25
- 239000000523 sample Substances 0.000 claims description 104
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 94
- 230000027455 binding Effects 0.000 claims description 93
- 108020004414 DNA Proteins 0.000 claims description 84
- 238000000034 method Methods 0.000 claims description 84
- 238000001228 spectrum Methods 0.000 claims description 80
- 239000000377 silicon dioxide Substances 0.000 claims description 38
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 24
- 238000004873 anchoring Methods 0.000 claims description 19
- 102000053602 DNA Human genes 0.000 claims description 17
- 239000013642 negative control Substances 0.000 claims description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108060002716 Exonuclease Proteins 0.000 claims description 11
- 102000013165 exonuclease Human genes 0.000 claims description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- 230000007613 environmental effect Effects 0.000 claims description 10
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 6
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000012071 phase Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 229910044991 metal oxide Inorganic materials 0.000 claims description 4
- 150000004706 metal oxides Chemical class 0.000 claims description 4
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000013060 biological fluid Substances 0.000 claims description 2
- 150000005829 chemical entities Chemical class 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- RUDFQVOCFDJEEF-UHFFFAOYSA-N yttrium(III) oxide Inorganic materials [O-2].[O-2].[O-2].[Y+3].[Y+3] RUDFQVOCFDJEEF-UHFFFAOYSA-N 0.000 claims description 2
- 108020000999 Viral RNA Proteins 0.000 claims 1
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 238000010839 reverse transcription Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000004005 microsphere Substances 0.000 description 122
- 238000009396 hybridization Methods 0.000 description 68
- 239000000243 solution Substances 0.000 description 58
- 230000005284 excitation Effects 0.000 description 46
- 108091034117 Oligonucleotide Proteins 0.000 description 45
- 239000012634 fragment Substances 0.000 description 35
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 33
- 239000002299 complementary DNA Substances 0.000 description 31
- 239000003570 air Substances 0.000 description 30
- 230000003595 spectral effect Effects 0.000 description 28
- 238000011282 treatment Methods 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000000872 buffer Substances 0.000 description 23
- 230000000295 complement effect Effects 0.000 description 22
- 239000002609 medium Substances 0.000 description 22
- 239000000126 substance Substances 0.000 description 22
- 230000035945 sensitivity Effects 0.000 description 20
- 238000010438 heat treatment Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 239000002773 nucleotide Substances 0.000 description 17
- 125000003729 nucleotide group Chemical group 0.000 description 17
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 16
- 239000000975 dye Substances 0.000 description 15
- 230000003287 optical effect Effects 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 239000011324 bead Substances 0.000 description 12
- 238000001444 catalytic combustion detection Methods 0.000 description 12
- 230000021615 conjugation Effects 0.000 description 12
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 11
- 238000004061 bleaching Methods 0.000 description 11
- 238000012512 characterization method Methods 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 230000010354 integration Effects 0.000 description 11
- 229960004592 isopropanol Drugs 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- -1 rare earth ions Chemical class 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000427 antigen Substances 0.000 description 10
- 238000011161 development Methods 0.000 description 10
- 239000011521 glass Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 238000000295 emission spectrum Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 238000011835 investigation Methods 0.000 description 9
- 239000002159 nanocrystal Substances 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 238000003491 array Methods 0.000 description 8
- 238000004891 communication Methods 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 8
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 150000003573 thiols Chemical class 0.000 description 7
- 239000003298 DNA probe Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 6
- 108010064978 Type II Site-Specific Deoxyribonucleases Proteins 0.000 description 6
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000005424 photoluminescence Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000012736 aqueous medium Substances 0.000 description 5
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- 108020003215 DNA Probes Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 108010027697 Type I Site-Specific Deoxyribonucleases Proteins 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000010804 cDNA synthesis Methods 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000007306 functionalization reaction Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000011859 microparticle Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 150000001345 alkine derivatives Chemical class 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000009510 drug design Methods 0.000 description 3
- 238000003205 genotyping method Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000003278 mimic effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 238000006557 surface reaction Methods 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- QCPFFGGFHNZBEP-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 QCPFFGGFHNZBEP-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical group SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091008605 VEGF receptors Proteins 0.000 description 2
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000006177 biological buffer Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 101150087654 chrnd gene Proteins 0.000 description 2
- 229910052681 coesite Inorganic materials 0.000 description 2
- 239000008119 colloidal silica Substances 0.000 description 2
- 239000011246 composite particle Substances 0.000 description 2
- 230000001268 conjugating effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 229910052906 cristobalite Inorganic materials 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 229920001002 functional polymer Polymers 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 238000002161 passivation Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000001782 photodegradation Methods 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 229910052761 rare earth metal Inorganic materials 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000004054 semiconductor nanocrystal Substances 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000002520 smart material Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 229910052682 stishovite Inorganic materials 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 235000001508 sulfur Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 229910052905 tridymite Inorganic materials 0.000 description 2
- 229940124676 vascular endothelial growth factor receptor Drugs 0.000 description 2
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 229910004613 CdTe Inorganic materials 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 102000012745 Immunoglobulin Subunits Human genes 0.000 description 1
- 108010079585 Immunoglobulin Subunits Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 229920005479 Lucite® Polymers 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- WPBJCXUUUSDQJO-UHFFFAOYSA-N Spermine dialdehyde Chemical compound O=CCCNCCCCNCCC=O WPBJCXUUUSDQJO-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108010067022 Type III Site-Specific Deoxyribonucleases Proteins 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009582 blood typing Methods 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
- 238000011162 downstream development Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 239000004030 hiv protease inhibitor Substances 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 238000011898 label-free detection Methods 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 238000011551 log transformation method Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002073 nanorod Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000011192 particle characterization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000011029 spinel Substances 0.000 description 1
- 229910052596 spinel Inorganic materials 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011030 tanzanite Substances 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011031 topaz Substances 0.000 description 1
- 229910052853 topaz Inorganic materials 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 241001624918 unidentified bacterium Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/7769—Measurement method of reaction-produced change in sensor
- G01N2021/7786—Fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
- G01N21/7746—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides the waveguide coupled to a cavity resonator
Definitions
- the present invention relates to the field of analyte detection. More particularly, the present invention relates to biosensing and rapid and sensitive analyte detection using a whispering gallery mode (WGM)-based assay.
- WGM whispering gallery mode
- WGM whispering gallery modes
- MDR morphology dependent resonances
- WGM technology is predicated, in part, on the phenomenon that fluorophores enable a distinctive WGM profile to be generated.
- the fluorophores are incorporated onto quantum dots which are into the microparticles by diffusion or may be incorporated during their manufacture.
- the type of fluorophore is unlimited and may for example be an organic dye, a rare earth based lumophore, a semiconductor nanocrystal of various morphologies and compositions, a phosphor or other material which emits light when illuminated. This fluorophore or mixture thereof is then attached to microspheroidal particles. When a target analyte interacts with a binding partner immobilized to the microspheroidal particle, the WGM profile changes, enabling detection of the binding event.
- WGM allow only certain wavelengths of light to be emitted from the particle.
- the result of this phenomenon is that the usual broad emission (10-lOOnm wide) bands from, for example, a fluorophore, become constrained and appear as a series of sharp peaks corresponding effectively to standing mode patterns of light within the particle.
- the WGM profile is extremely sensitive to changes at the surface of the microspheroidal particle and the WGM profile changes when the microspheroidal particle interacts with analytes or molecules within its environment.
- the present invention provides a sensitive method and reagents based on whispering gallery mode (WGM) detection assays, for, inter alia, detecting analytes in a sample.
- WGM whispering gallery mode
- the method and reagents of the present invention are predicated, in one part, on the unexpected determination that the coating of microspheres with a fluorophore per se, as opposed to using discrete quantum dots, enhances the sensitivity of the WGM-based detection.
- the selection of particle such as a particle with functionalized chemical groups on its surface increases sensitivity when either quantum dots or direct fluorophore coating occurs.
- the particle is selected having a higher refractive index relative to the medium in which the assay is conducted.
- the microspheroidal particle has a refractive index greater than 1.40.
- one aspect of the present invention provides a method of analyte detection in a medium, the method comprising subjecting microspheres coated with a fluorophore and a multiplicity of ligands to WGM detection means to identify a binding event between one or more ligands and a ligand binding analyte.
- the present invention provides a method of analyte detection in a medium, the method comprising subjecting microspheres wherein the microspheres have a higher refractive index than the medium comprising the analyte coated with a fluorophore and a multiplicity of ligands to WGM detection means to identify a binding event between one or more ligands and a ligand binding analyte.
- the microspheroidal particle has a refractive index greater than 1.40.
- Another aspect of the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore-conjugated microspheroidal particles; (ii) contacting the microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means to detect a binding event.
- Another aspect of the invention comprises, a method for detecting an analyte in a medium, comprising the steps of:
- the microspheroidal particles are functionalized by chemical moieties such as with azide, alkyne, amine, aldehyde, sulfate or thiol, carboxyl, carboxylate and/or hydroxyl groups.
- the microspheroidal particles are amine-aldehyde particles such as but not limited to melamine particles or melamine formaldehyde particles.
- another aspect of the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore-conjugated functionalized microspheroidal particles; (ii) contacting the functionalized microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the functionalized microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means to detect a binding event.
- the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore-conjugated amine-aldehyde microspheroidal particles; (ii) contacting the amine-aldehyde microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the amine-aldehyde microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the amine-aldehyde microspheroidal particles to WGM detection means to detect a binding event.
- the amine-aldehyde particles are melamine formaldehyde particles.
- the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore-conjugated melamine formaldehyde microspheroidal particles; (ii) contacting the melamine formaldehyde microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the melamine formaldehyde microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the melamine formaldehyde microspheroidal particles to WGM detection means to detect a binding event.
- the particles may also comprise quantum dots.
- another aspect of the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of melamine formaldehyde microspheroidal particles comprising fluorophore-coated quantum dots; (ii) contacting the microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means to detect a binding event.
- Another aspect of the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of microspheroidal particles having a higher refractive index than the medium comprising the analyte, the microspheroidal particles encoding a fluorophor; (ii) contacting the microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means to detect a binding event.
- Yet another aspect of the present invention provides a method of detecting an analyte, the method comprising contacting at least one population of microspheroidal particles with a sample putatively comprising the analyte, wherein each particle within a population of microspheroidal particles comprises a fluorophore which emits visible radiation in response to infrared excitation and an immobilized putative binding partner of the analyte wherein each particle population has a defined WGM profile, wherein binding of the analyte to the immobilized binding partner results in a change in the WGM profile of the at least one population of microspheroidal particles which is indicative of the presence of the analyte.
- the analyte or its respective ligand comprises a molecule selected from the list consisting of: nucleic acid; protein; peptide; antibody; lipid; carbohydrate; and any small molecule or chemical entity, including cells (e.g. cancer cells), bacteria and viruses.
- the ligands anchored to the microspheroidal particles are nucleic acid molecules and the analytes to be detected are complementary nucleic acid molecules.
- the nucleic acid ligand or analyte is a DNA molecule comprising a single-stranded DNA sequence.
- Another aspect of the present invention provides the use of a method comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore- conjugated microspheroidal particles; (ii) contacting the microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means in the manufacture of an assay to detect a binding event between an analyte and a ligand.
- the microspheres may be re-cycled.
- the assay may be conducted in any medium such as air or other gas or in a liquid phase such as an aqueous solution, biological buffer or complex biological fluid.
- the present invention provides a kit comprising fluorophore- conjugated microspheroidal particles and a multiplicity of ligands for anchoring thereto, for detecting a binding event between a ligand and an analyte by WGM detection means.
- the kit comprises fluorophore-conjugated microspheroidal particles to which a multiplicity of ligands has been attached.
- the fluorophore may be coated on an organic dye or a quantum dot.
- the present invention provides a biosensor comprising WGM detection means wherein the biosensor is a self-contained unit comprising a power source, light source, sample-handling chamber and a spectrophotometer.
- SEQ ID NO Nucleotide and amino acid sequences are referred to by a sequence identifier number (SEQ ID NO).
- the SEQ ID NOs correspond numerically to the sequence identifiers ⁇ 400>l (SEQ ID NO: I), ⁇ 400>2 (SEQ ID NO:2), etc.
- a summary of the sequence identifiers is provided in Table 1.
- a sequence listing is provided after the claims.
- Figure 1 is a graphical representation of WGM DNA biosensing demonstrating consistent and measurable shifts after binding. These measurements have been carried out in an aqueous solution containing pH buffers and an electrolyte. A demonstrable shift in WGM profile was observed for each of beads 9, 10, 11 and 12 (A 3 B, C and D respectively) after the beads or microspheroidal particles were contacted with a nucleic acid analyte complementary to the nucleic acid analyte-binding partner anchored to the surface of the beads. Each of the beads was 5.6 ⁇ m in diameter.
- FIG. 2 is a schematic representation of the WGM detection means and apparatus.
- Figure 3 is a graphical representation of WGM spectra generated with incident light of 6.3 ⁇ W, 50.2 ⁇ W, 214.5 ⁇ W and 1,160.5 ⁇ W (A, B, C and D respectively).
- the light source had a wavelength of 532 nm and the exposure time was 200 ms.
- Figure 4 is a graphical representation of WGM profile generated following illumination of microspheroidal particles with incident light (532 nm, 50 ⁇ W) for 10, 60, 200 and 1,000 ms (A, B, C and D, respectively). Visibility decreased gradually up to 5 seconds exposure time (E).
- Figure 5 is a photographic image of microspheroidal particles of the present invention immobilized on the surface of a glass coverslip.
- Figure 6 is a photographic representation showing the simplified chemical reaction steps using a silica particle functionalized with mercaptan groups. Through covalent bonding the conjugation of fluorescently labeled acryloyl-single strand oligonucleotide fragments is achieved. This process leads to the robust cost effective fabrication of fluorescent microspheres which propagate WGM.
- Figure 7 is a graphical representation showing the plot of the peak positions of four major WGM peaks from a single microsphere as a function of the assay stage at which they were recorded. The plot clearly demonstrates the four major peaks red shift during hybridization, blue shift during denaturing and red shift again upon re-exposure to the target.
- Figure 8 is a photographic representation showing an overview of particle synthesis and WGM hybridization assay.
- Part A) indicates the key features of the 70 base enl oligonucleotide-modified 7.50 ⁇ m SiO 2 microspheres.
- TMR dye-label tetramethyl rhodamine
- Part B) Particle assay plate preparation particles are immobilized on the hybridization substrate which follows the acquisition of emission signal (pre-treatment);
- Part D) The final step involves the analysis of the pre/post-emission signals from a single particle, the peak positions from the acquired spectra are compared to determine the effect of the treatment solution.
- Figure 9 is a photographic representation showing typical WGM emission signal outputs and single particle spectroscopy.
- a typical emission signal captured in air from an excited 7.50 ⁇ m oligo-modified silica particle using two WGM characterization set-ups A) Coupled to an Ocean Optics spectrometer ( ⁇ 0.9 run) and B) Triax spectrometer ( ⁇ 0.05 run); C) The concept of single particle spectroscopy, the schematic shows two particles, labeled microsphere A and B each from the same sample, both particles have been identically chemically modified. Note the emission signals acquired from the individual particles are distinctly unique.
- Figure 10 is a graphical representation showing single microsphere spectral shift data from a selection of sensors used in a concentration based cDNA hybridization assay.
- Figure 11 is a schematic illustration of the reaction chemistry utilized to functionalize raw melamine formaldehyde (MF) particles with labeled single-strand- oligonucleotide fragments. Note the reaction is completed in a single step at room temperature using buffer only. The fragments covalently bind with -NH groups on the particle surface.
- MF melamine formaldehyde
- Figure 12 is a graphical representation showing particle excitation was achieved through an 80 W mercury lamp and a 420-490 nm filter block. Emission signals captured in air and water from 7.50 ⁇ m 30 base (TMR) oligo-modified microspheres.
- Figure 13 is a graphical representation showing emission signal measurements, taken using assay plates derived of several composite materials; Particle excitation was achieved through an 80 W mercury lamp and a 420-490 nm filter block.
- FIG 14 is a graphical representation showing heat stability analysis of oligonucleotide (TMR) functionalized 7.52 ⁇ m MF particles. Particles were immersed in solution under constant heat at 9O 0 C over a 3 hr period in Milli-Q, Buffer or MES (pH 5.4).
- TMR oligonucleotide
- a WGM was collected from each test particle utilizing an 80 W mercury lamp and a 420-
- FIG. 15 is a graphical representation showing thermo-cycled hybridization binding study.
- a two-step temperature gradient (37 0 C - 72 0 C) was created using a thermo- regulated microscope stage coupled to the confocal/ TRIAX setup.
- the target DNA (T m 71.2 0 C) was complementary to the rslO434 target fragments attached to the particle.
- Hybridization cycles were completed on a single microsphere with Milli-Q H 2 O (control) and target DNA.
- a fluorescence signal was captured at each temperature gradient and the A ⁇ was observed.
- Figures 16(A) and (B) are graphical representations showing (A) Melamine beads WGM solid lines: Solid lines are WGM of single melamine formaldehyde beads obtained in air. Spectra acquired in aqueous media are shown in dotted lines; (B) Silica beads WGM: Solid lines are WGM of single silica beads obtained in air. Spectra acquired in aqueous media are shown in dotted lines. Acquisition in water yielded very faint fluorescence and no WGM.
- Figure 17 is a graphical representation of the antibody WGM immuno-assay. A single 7.52 ⁇ m MF particle functionalized with a FITC labeled human ⁇ -IgM antibody was immobilized in a single micro-well.
- the entire assay was performed at room temperature.
- the untreated particle was excited through a Ar+ laser to obtain a reference signal, then treated with Milli-Q followed by unlabeled human IgM.
- the representative peak-set indicates a typical red shift of several nanometres which resulted following IgM treatment. A minimal shift was noted 30 min after the addition.
- Spectra were acquired through a Triax 550/CCD confocal setup (spectral resolution + 0.05 nm).
- a ligand includes a single ligand, as well as two or more ligands
- reference to “an analyte” includes a single analyte, as well as two or more analytes
- reference to “the fluorophore” includes a single fluorophore, as well as two or more fluorophores
- reference to “the invention” includes single or multiple aspects of an invention; and so forth.
- the present invention provides a multiplicity of analyte-binding partners or ligands conjugated to fluorophore-coated microspheroidal particles. When these particles are illuminated, a "baseline" whispering gallery modes (WGM) spectrum or profile is emitted. Each population of microspheroidal particles has a unique WGM baseline signature. This baseline profile is altered by binding of analytes to the analyte-binding partner or ligand on the surface of the microspheroidal particles, causing a detectable shift in the WGM spectrum.
- WGM whispering gallery modes
- the microspheroidal particles of the present invention comprise microspheres coated with fluorophores, which, when illuminated, emit fluorescent light. The emitted light is trapped within the microsphere and resonates within the sphere creating a spectrum of discrete wavelengths termed whispering gallery modes or "WGM" .
- the coating of the microspheroidal particles with a fluorophore as opposed to using discrete quantum dots enhances the sensitivity of WGM-based detection.
- the present invention extends to microspheroidal particles coated with a fluorophore (i.e. without using quantum dots) or the use of quantum dots in combination with melamine formaldehyde particles.
- the microspheroidal particles may also be selected on the basis that they have a higher refractive index relative to the medium comprising the analyte. In an embodiment, the microspheroidal particle has a refractive index greater than 1.40.
- quantum dot or “QD” is to be understood as encompassing particles known in the art as semiconductor nanoparticles, nanocrystals, quantum dots, or Qparticles.
- microspheroidal particles and “microspheres” are used interchangeably herein and include spherical particles comprising any material, homogenous or otherwise which can produce one or more WGM profiles based on its fluorophore. As will be evident to those of skill in the art, almost any material, homogenous or otherwise, may be used for the microspheroidal particle.
- the microspheroidal particles contemplated herein may also comprise more than one substance, and as such may comprise shells, alloys or mixtures of organic and/or inorganic substances.
- the microspheroidal particle comprises a substantially homogenous material with an isotropic refractive index and which is also non-absorbing (other than the fluorophore, which is further described below).
- the microspheroidal particles of the present invention comprise a material selected from the list consisting of: melamine or a chemical derivative thereof such as melamine formaldehyde; silica; latex; titania; tin dioxide; yttria; alumina; other binary metal oxides; perovskites and other piezoelectric metal oxides; PLGA; sucrose; agarose; and other polymers.
- the microspheroidal particles are functionalized by chemical moieties such as with amine, aldehyde, sulfate or thiol, carboxyl, carboxylase and/or hydroxyl groups.
- the microspheroidal particles are amine-aldehyde particles such as but not limited to melamine formaldehyde (MF) particles.
- MF particles provide a robust conjugation substrate for acryloyl modified target oligonucleotides and proteins to bind. The covalent bond remains intact after exposure to high pH solutions and extreme temperatures, as a high quality WGM can acquire post-treatment.
- Melamine is a trimer of cyanamide and is also known as: l,3,5-triazine-2,4,6- triamine; 2,4,6-triamino-s-triazine; cyanurotriamide; cyanurotriamine or cyanuramide.
- the melamine is melamine formaldehyde.
- the present invention also extends to the use of magnetic particles in the WGM assay. Such particles could be presented in very precise fixed positions. Magnetic facilitated particle immobilization enables discrete single particle analysis and alleviates the need to fabricate custom immobilization substrates.
- high refractive index particles are selected which support WGM in solution such as colloidal silica, zirconia or titania.
- microspheres shelled with higher refractive index materials provide useful ideal sensor platform. These particles contain high order radial modes within the adsorbed layer and as a result should enable the acquisition of high Q WGM spectra which contain the high order modes.
- a fluorescently stable particle which supports WGM in solution may be produced by the adsorption of a monolayer of nanocrystals to a homogenous microsphere followed by a stabilizing high refractive index shell.
- a list of commercially available high refractive index materials and particles is provided below.
- fluorophore is general and is not limited to organic dyes, but includes any chemical, molecule or material, which has the property of emitting light of a well defined wavelength when illuminated. This includes but is not restricted to; organic dyes, organometallic complexes, quantum dots (including nanorods, nanowires and other morphologies, coated and uncoated QDs, alloys and mixtures thereof.), rare earth ions or mixtures thereof, upconverters and also infra-red emitting fluorophores, which may be advantageous in absorbing samples. Other materials may also be incorporated such as defective fluorescent materials such as diamond containing Nitrogen induced defects or vacancies.
- WGMs may be generated by fluorophores that are attached to the surface of the microsphere, but may also be generated when the fluorophore is embedded or distributed within the microsphere.
- the distribution of fluorophores affects the intensity of different modes of the WGM, but for the purposes of this invention, no distinction is made between fluorophores that are on the surface or within the microsphere.
- Titania TiO 2 (2.20), Aluminium Al 2 O 3 (1.77), Mylar (1.65), Copper Cu (2.43), Platinum Pt (2.33)
- the present invention is predicated, in part, on the determination that WGM detection means do not require microspheres to be coated with quantum dots.
- one aspect of the present invention provides a method of analyte detection in a medium, the method comprising subjecting microspheres coated with a fluorophore and a multiplicity of ligands to WGM detection means to identify a binding event between one or more ligands and a ligand binding analyte.
- the present invention provides a method of analyte detection in a medium, the method comprising subjecting microspheres wherein the microspheres have a higher refractive index than the medium comprising the analyte coated with a fluorophore and a multiplicity of ligands to WGM detection means to identify a binding event between one or more ligands and a ligand binding analyte.
- Another aspect of the present invention provides, a method for detecting an analyte in a medium, comprising the steps of:
- fluorophore refers to any molecule which exhibits the property of fluorescence.
- fluorescence may be defined as the property of a molecule to absorb light of a particular wavelength and re-emit light of a longer wavelength. The wavelength change relates to an energy loss that takes place in the process.
- fluorophore may encompass a range of fluorophores such as chemical fluorophores and dyes.
- the fluorophore may be chosen to emit at any wavelength at which WGM profile may be easily resolved. This depends on the ratio of the wavelength of the emission to the particle radius. Given that the sphere radius is arbitrary, the emission may be suitably chosen from the ultraviolet (wavelength range of about 350nm to about 3nm), visible (wavelength range of about 350nm to about 800nm), near infrared ([NIR)] (wavelength range of about 800nm to about 1500nm) and/or infrared ([IR)] (wavelength range of about 1500nm to about lO ⁇ m) ranges. However, due to the ease of detection, in one particularly preferred embodiment, the fluorophore is detectable in the visible wavelength range.
- the fluorophore emits visible radiation in response to Infrared excitation.
- fluorophores are also referred to herein as "upconverters”.
- another aspect of the present invention provides a method of detecting an analyte, the method comprising contacting at least one population of microspheroidal particles with a sample putatively comprising the analyte, wherein each particle within a population of microspheroidal particles comprises a fluorophore which emits visible radiation in response to infrared excitation and an immobilized putative binding partner of the analyte wherein each particle population has a defined WGM profile, wherein binding of the analyte to the immobilized binding partner results in a change in the WGM profile, when compared to the baseline WGM profile, of at least one population of microspheroidal particles which is indicative of the presence of the analyte.
- the microspheroidal particles are functionalized by chemical moieties such as with amine, thiol and/or aldehyde groups, sulfate, carboxylate, hydroxyl groups, axide and/or alkynes.
- amine-aldehyde-based particles such as melamine formaldehyde, provide a usefuls substrate for acryloyl modified target oligonucleotides and proteins to bind.
- another aspect of the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore-conjugated functionalized microspheroidal particles; (ii) contacting the functionalized microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the functionalized microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means to detect a binding event.
- the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore-conjugated amine-aldehyde microspheroidal particles; (ii) contacting the amine-aldehyde microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the amine-aldehyde microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the amine-aldehyde microspheroidal particles to WGM detection means to detect a binding event.
- the amine-aldehyde particles are melamine formaldehyde.
- the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of fluorophore-conjugated melamine formaldehyde microspheroidal particles; (ii) contacting the melamine formaldehyde microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the melamine formaldehyde microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the melamine formaldehyde microspheroidal particles to WGM detection means to detect a binding event.
- quantum dots may also be used.
- another aspect of the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of melamine formaldehyde microspheroidal particles comprising fluorophore-coated quantum dots; (ii) contacting the microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means to detect a binding event.
- Another aspect of the present invention provides a method for detecting a binding event between an analyte and a ligand, comprising the steps of: (i) anchoring a multiplicity of ligands to a population of microspheroidal particles having a higher refractive index than the medium comprising the analyte, the microspheroidal particles encoding a fluorophor; (ii) contacting the microspheroidal particles with a negative control sample and determining a baseline spectrum; (iii) contacting the microspheroidal particles with a sample putatively comprising the analyte for a time and under conditions sufficient to facilitate a binding event between the analyte and its respective ligand; and (iv) subjecting the microspheroidal particles to WGM detection means to detect a binding event.
- fluorescent dyes which are available in the art which may be used as fluorophores in accordance with the present invention.
- An important property of a fluorescent dye or other fluorophore, which determines its potential for use is the excitation wavelength of the fluorophore; it must match the available wavelengths of the light source.
- fluorescent dyes and other fluorophores will be familiar to those of skill in the art, and the choice of fluorescent marker in no way limits the subject invention.
- Convenient "fluorophores" which may be used for the labeling of a microspheroidal particle comprise any fluorescent marker which is excitable using a light source selected from the group below:
- Argon ion lasers - comprise a blue, 488 nm line, which is suitable for the excitation of many dyes and fluorochromes that fluoresce in the green to red region.
- Tunable argon lasers are also available that emit at a range of wavelengths (458 nm, 488 nm, 496 nm, 515 nm amongst others).
- Diode lasers - have an emission wavelength of 635 nm. Other diode lasers which are now available operate at 532 nm. This wavelength excites propidium iodide (PI) optimally. Blue diode lasers emitting light around 476 nm are also available. Such diode lasers may be conveniently employed to excite WGMs within the microspheroidal particles.
- HeNe gas lasers - operate with the red 633 nm line. Such lasers may be conveniently employed to excite WGMs within the microspheroidal particles.
- LEDs Light Emitting Diodes
- HeCd lasers - operate at 325 nm. Such lasers may be conveniently employed to excite WGMs within the microspheroidal particles.
- the fluorescent markers are selected from: Alexa Fluor dyes; BoDipy dyes, including BoDipy 630/650 and BoDipy
- Cy dyes particularly Cy3, Cy5 and Cy 5.5; 6-FAM (Fluorescein); Fluorescein dT; Hexachlorofluorescein (HEX); 6-carboxy-4', 5'-dichloro-2', T- dimethoxyfluorescein
- Rhodamine Green Rhodamine Green and ROX
- Carboxytetramethylrhodamine TAMRA
- Tetrachlorofluorescein TAT
- Two dyeing techniques are commonly used to fluorescently label microspheroidal particles.
- the two techniques produce particles with unique properties, each beneficial for different applications.
- Internal dyeing produces extremely stable particles with typically narrow fluorescence emissions. These particles often display a greater resistance to photobleaching.
- surface groups are available for use in conjugating ligands (proteins, antibodies, nucleic acids, etc.) to the surface of the bead. For this reason, internally labeled particles are typically used in analyte-detection and immunoassay applications.
- Surface- labeling involves conjugation of the fluorophore to the microspheroidal particle surface.
- the fluorophores are on the surface of the particle, they are able to interact with their environment just as the fluorophores on a stained cell.
- the result is a particle standard that exhibits the same excitation and emission properties as stained cell samples, under a variety of different conditions, such as the presence of contaminants or changes in pH.
- the "environmentally responsive" nature of surface-labeled particles makes them ideally suited for mimicking biological samples. Externally labeled particles are frequently used as controls and standards in a number of applications utilizing fluorescence detection.
- the present invention contemplates the association of a particle with a fluorescent label via any means.
- fluorophore should be understood to also encompass multiple fluorophores, and mixtures of fluorophores. The use of all such fluorophores on microspheroidal particles is to be considered as being within the scope of the methods and reagents described herein.
- the emission of any particular fluorophore depends on the distribution of the fluorophore in the microspheroidal particle, the type of fluorophore and the concentration of fluorophore.
- the methods of the present invention are still practicable irrespective of whether the fluorophore is at the surface of the microspheroidal particle, present as a shell within the microspheroidal particle, located at the core of the microspheroidal particle or is present in more than one of the recited locations.
- the methods of the present invention are not predicated on quenching of the emission from the fluorophore.
- the methods of the present invention are predicated, in part, on a modulation (i.e. a change) in the WGM profile of the fluorophore as a result of an interaction or association of an analyte with a binding partner immobilized to the surface of a microspheroidal particle.
- WGM when dealing with electromagnetic radiation, are electromagnetic resonances that can be established when incident light interacts with a particle of higher refractive index than its surrounding medium. WGM occur at particular resonant wavelengths of light for a given particle size, and the nature of the WGM may change with, inter alia, the size of the particle containing the WGM and the refractive indices of both the particle and the surrounding medium. Furthermore, the size of the particle can also affect the WGM established therein. WGM are established when the incident light undergoes total internal reflection at the particle surface.
- Total internal reflection may occur at the interface between two non- absorbing media.
- TIR Total internal reflection
- a beam of light propagating in the medium of higher refractive index meets an interface at a medium of lower refractive index at an angle of incidence above a critical angle
- the light is totally reflected at the interface and propagates back into the high refractive index medium.
- the light may be reflected many times within the particle of higher refractive index.
- the light is concentrated near the circumference of the particle and can be assigned a mode number and a mode order.
- the mode number, n provides the number of wavelengths around the circumference of the particle
- the mode order, / provides the number of maxima in the radial dependence of the electromagnetic field within the particle.
- Fluorescence emitters embedded on a particle display defined WGM profiles. These modes allow only certain wavelengths of light to be emitted from the particle. The result of this phenomenon is that the usual relatively broad emission spectrum of a fluorophore (for example, fluorophores typically emit in a 10-100 nm wide band) becomes constrained and appears as a series of sharp "peaks" corresponding effectively to standing mode patterns of light within the particle.
- the series of peaks generated as a result of the establishment of a WGM in the microspheroidal particle of the present invention are referred to herein as "whispering gallery mode profiles" or "WGM profiles”.
- the WGM profile is extremely sensitive to both the position of the embedded fluorophore and their concentration and spatial configuration with respect to each other. Particle size and refractive index are the 2 most important parameters in determining the emission wavelengths seen in a WGM profile.
- the position and amplitude of one or more peaks in a WGM profile may be strongly influenced by interactions or associations of the microspheroidal particle with molecules in a sample or external environment.
- association or binding of a molecule to a microspheroidal particle alters the effective refractive index of the microspheroidal particle altering the WGM profile generated by the microspheroidal particle.
- Any number of means known in the art are suitable for conjugating fluorophores to the surface of microspheres.
- Microsphere surfaces can be optimized or functionalized for hydrophobic adsorption or covalent attachment of molecules including fluorophores or any biological or chemical molecule.
- the present invention does not extend to and specifically excludes the use of quantum dots to label the microspheres.
- microspheres can be functionalized by the addition of any number of functional groups including: azide, alkyne, maleimide, succinimide, epoxide, methacrylate, acryloyl, amine, aldehyde, sulfate or thiol; carboxyl; carboxylate; hydroxyl; etc.
- nucleic acid molecules are bound covalently to a sulfur-coated surface of a silica microsphere. Silanization with 3-mercaptopropyltrimethoxysilane followed by exhaustive washing is used to create this surface.
- Nucleic acid molecules for example, DNA oligonucleotides, are manufactured with 5' thiol or acryl groups and are attached to the free sulfurs on the surface.
- the ligands of the present invention are in no way limited to any one species and include ligands selected from the group consisting of: nucleic acids; antibodies; peptides; polypeptides; carbohydrates; lipids; glycoproteins; lipoproteins; lipopeptides; lipopolysaccharides; small organic molecules and small inorganic molecules.
- ligands selected from the group consisting of: nucleic acids; antibodies; peptides; polypeptides; carbohydrates; lipids; glycoproteins; lipoproteins; lipopeptides; lipopolysaccharides; small organic molecules and small inorganic molecules.
- the particles When coated with an antigen or antibody, the particles are used in an "immuno-WGM” assay or "immuno-based WGM” assay.
- nucleic acids include RNA, cDNA, genomic DNA, synthetic forms and mixed polymers, both sense and antisense strands, and may be chemically or biochemically modified or may contain non-natural or derivatized nucleotide bases, as will be readily appreciated by those skilled in the art.
- modifications include, for example, labels, methylation, substitution of one or more of the naturally occuring nucleotides with an analog (such as a morpholine ring), internucleotide modifications such as uncharged linkages (eg.
- synthetic molecules that mimic polynucleotides in their ability to bind a designated sequence via hydrogen bonding and other chemical interactions. Such molecules are known in the art and include, for example, those in which peptide linkages substitute for phosphate linkages in the backbone of the molecule.
- antibody refers to a protein of the immunoglobulin family that is capable of combining, interacting or otherwise associating with an antigen.
- An antibody is, therefore, an antigen-binding molecule.
- antigen is used herein in its broadest sense to refer to a substance that is capable of reacting with or binding to the antigen- binding site of an antibody. With reference to the present invention, an antigen also includes the idiotype of an antibody.
- immunoglobulin is used herein to refer to a protein consisting of one or more polypeptides substantially encoded by immunoglobulin genes.
- the recognized immunoglobulin molecules include the K, ⁇ , ⁇ , ⁇ (IgG 1 , IgG 2 , IgG 3 , IgG 4 ), ⁇ , ⁇ and ⁇ constant regions, light chains (K and 1), as well as the myriad immunoglobulin variable regions.
- One form of immunoglobulin constitutes the basic structural unit of an antibody. This form is a tetramer and consists of two identical pairs of immunoglobulin chains, each pair having one light and one heavy chain.
- immunoglobulins may exist in a variety of other forms including, for example, Fv, Fab, Fab' and (Fab') 2 and chimeric antibodies and all of these variants are encompassed by the term "antibody” as used herein.
- immunoglobulins from other animals eg. birds, mammals, fish, amphibians, and reptiles
- the analyte-binding ligand is a DNA molecule comprising a single-stranded DNA overhang
- the analyte to be detected is a nucleic acid molecule capable of hybridizing to the ligand.
- hybridization occurs, a shift in WGM profile is detectable. Conversely, when there is no hybridization between complementary nucleic acid sequences, no shift in WGM profile occurs.
- the analyte-binding partners or ligands are DNA molecules prepared by: (i) digestion of double-stranded DNA with an enzyme that generates a single-stranded DNA overhang, for example, a restriction endonuclease; and (ii) digestion with an exonuclease enzyme.
- the resultant digested DNA comprises single- stranded DNA capable of hybridizing to, inter alia, complementary single-stranded nucleic acids.
- Restriction endonuclease as used herein means a nuclease enzyme that hydrolyses nucleotides at specific sequences within a DNA molecule. Restriction endonucleases comprise Type I, Type II and Type III restriction endonucleases.
- Table 2 lists a subset of Type I and Type II restriction endonucleases that generate 5'-overhangs of 4 bases.
- Table 3 lists a subset of Type I and Type II restriction endonucleases that generate 3 '-overhangs, mostly four bases in length.
- Exonuclease as used herein means a nuclease enzyme that hydrolyzes nucleotides from the ends of DNA strands.
- an exonuclease enzyme suitable for the preparation of the analyte-binding ligands and/or the analytes to be detected is lambda ( ⁇ ) exonuclease.
- Lambda exonuclease is a double-stranded DNA exonuclease which degrades double-stranded DNA in a 5'- to 3'- direction. Lambda exonuclease requires the 5'-end of the DNA to be double-stranded and phosphorylated. Lambda exonuclease digestion can be used to preferentially degrade specific strands of double-stranded DNA to generate single- stranded DNA analyte-binding ligands and analytes to be detected.
- microspheroidal particles of the present invention are coated with nucleic acids derived from a pathogenic agent such as a virus, bacterium, yeast or parasite.
- the detection of a binding event is indicative of the presence of complementary nucleic acids in the sample and therefore, is indicative of the presence of the agent in the sample and/or at the source of the sample.
- "Complementary" as used herein refers to the capacity for precise pairing between two nucleobases of an oligomeric compound.
- a nucleobase at a certain position of an oligonucleotide is capable of hydrogen bonding with a nucleobase at a certain position of a target nucleic acid, said target nucleic acid being a DNA, RNA, or oligonucleotide molecule
- the position of hydrogen bonding between the oligonucleotide and the target nucleic acid is considered to be a complementary position.
- the oligonucleotide and the further DNA, RNA, or oligonucleotide molecule are complementary to each other when a sufficient number of complementary positions in each molecule are occupied by nucleobases which can hydrogen bond with each other.
- the present invention is particularly useful for testing for the presence of a wide array of analytes in a single sample.
- the present invention is useful for the detection of rare analytes which are present in a sample at low concentrations.
- the invention is useful for the detection of trace elements or contaminants such as allergens, pyrogens and microbiological or chemical contaminants in foods and medicines; pollutants or toxicants in environmental and industrial samples; explosives; agents of bio-terrorism; etc.
- trace elements or contaminants such as allergens, pyrogens and microbiological or chemical contaminants in foods and medicines; pollutants or toxicants in environmental and industrial samples; explosives; agents of bio-terrorism; etc.
- the term "rare” means infrequently occurring or uncommon or relatively few in number or relatively low in concentration.
- the present invention is also useful for the identification of analytes previously not known to bind to a particular ligand.
- the microspheroidal particles are coated with an enzyme or a receptor molecule in which the conformation of the catalytic site or putative ligand-binding site is intact.
- Analytes that bind to such particles represent putative agonists or antagonists of enzyme activity or receptor-ligand binding.
- the present invention is useful for drug identification and design.
- Rational drug design permits the production of structural analogs of biologically active polypeptides of interest or of small molecules with which they interact (e.g. agonists, antagonists, inhibitors or enhancers) in order to fashion drugs which are, for example, more active or stable forms of the polypeptide, or which, e.g. enhance or interfere with the function of a polypeptide in vivo. See, e.g. Hodgson (Bio/Technology 9:19-21, 1991). In one approach, one first determines the three-dimensional structure of a protein of interest by x-ray crystallography, by computer modeling or most typically, by a combination of approaches.
- Useful information regarding the structure of a polypeptide may also be gained by modeling based on the structure of homologous proteins.
- An example of rational drug design is the development of HIV protease inhibitors (Erickson et al, Science 249:527-533, 1990).
- target molecules may be analyzed by an alanine scan (Wells, Methods Enzymol. 202:2699-2705, 1991).
- an amino acid residue is replaced by Ala and its effect on the peptide's activity is determined.
- Each of the amino acid residues of the peptide is analyzed in this manner to determine the important regions of the peptide.
- the present invention is useful for the detection of genes or their encoded proteins associated with specific pathological conditions and diseases.
- the microspheroidal particles of the invention are coated with a specific ligand or library of ligands known to be expressed in human cancer, or conversely, with an antibody or library of antibodies specific for an antigen or antigens known to be associated with cancer. Therefore, the detection of a binding event is indicative of the presence in a sample of an analyte known to be associated with cancer. Due to its sensitivity, the WGM detection means of the present invention provides, inter alia, a method for the early detection of cancer.
- the ligand or analyte to be detected comprises a single nucleotide polymorphism (SNP) or a specific post-translational modification.
- SNP single nucleotide polymorphism
- the methods of the present invention are useful for several applications in the fields of, for example, medicine, veterinary science, agriculture, forensic science, biotechnology, food technology, sports science, nutritional science, manufacturing, drug design and development, biodefence, detection of explosive materials, insecticides, fertilisers and toxins.
- the methods of the present invention are useful for diagnosis of pathological conditions or diseases including genetic diseases, cancer, autoimmune disorders, allergies, infectious diseases, heart disease, neurological disease, proteopathies, and metabolic diseases, virus and bacterial diseases and contamination, identification of unknown bacteria or viruses or other microorganisms in natural samples..
- the methods of the present invention are useful for, inter alia, tissue typing, blood typing, genetic testing, drug testing, analysis of blood analytes, alcohol testing, pregnancy testing, etc.
- a "biological sample” is to be understood as a sample derived from a biological source such as an environmental sample, organism extract, plant or animal extract, serum, urine, exudate, semen, plasma, soil sample, river or sealed sample, extra-terrestrial sample, amongst other sources.
- biosensor as used herein means a sensor device for detecting quantities of, including very small quantities, or changes in a biochemical or chemical substance, in which an intermolecular binding event is registered and translated into data.
- Biosensing as used herein means any of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction into a quantifiable physical signal.
- biosensing applications of the invention are in no way limited and include: environmental applications e.g. the detection of pesticides and river water contaminants; remote sensing of airborne bacteria or spores thereof e.g. in counter-bioterrorist activities; detection of pathogens; determining levels of toxic substances before and after bioremediation; detection of organophosphates; routine analytical measurement of biochemical analytes; detection of drug residues in food, such as antibiotics and growth promoters; drug discovery and evaluation of the biological activity of new compounds.
- environmental applications e.g. the detection of pesticides and river water contaminants
- remote sensing of airborne bacteria or spores thereof e.g. in counter-bioterrorist activities
- detection of pathogens determining levels of toxic substances before and after bioremediation
- detection of organophosphates routine analytical measurement of biochemical analytes
- detection of drug residues in food such as antibiotics and growth promoters
- drug discovery and evaluation of the biological activity of new compounds include: environmental applications e
- the present invention provides, inter alia, an optical biosensor based upon the WGM detection system.
- the biosensor is compact and portable.
- the biosensors of the present invention provide a means for the rapid and sensitive detection of analytes.
- the biosensor is particularly adapted for convenient use in research and analytical laboratories and in the field.
- the WGM detection apparatus per se is adaptable to self-containment, miniaturization and portability. Importantly, this adaptability allows for rapid and convenient analyte detection on the bench-top or in the field, without any requirement for bulky and expensive components.
- the WGM detection apparatus does not require a bulky power source or light source, nor an expensive spectrophotometer or optical lens.
- some embodiments provide a 6OX microscope objective lens and a non-chilled spectrophotometer is used with a 0.5 nm slit width.
- the WGM detection apparatus is a biosensor.
- a power source of about 10 ⁇ W to about 2000 ⁇ W is sufficient to generate WGM spectral data according to the methods of the present invention.
- the fiuorophore-conjugated microspheroidal particles of the present invention are exposed to light for about 20-2000 milliseconds.
- Light at a wavelength of 532 nM is particularly suitable for generating WGM spectra according to the present invention.
- the microspheroidal particles of the invention are immobilized by "baking" to a solid support matrix, e.g. glass.
- the solid support comprises material through which light in the infra-red, visible and ultra-violet spectra can travel.
- microspheres are dried to a glass surface for times greater than 10 minutes at temperatures above 4O 0 C.
- a key requirement of the system is that spectra can be automatically compared and differences between before and after binding can be quantified. This has been accomplished by using a log transformation of the time-mode spectrum.
- kits for analyte detection by WGM means comprise fiuorophore-conjugated microspheroidal particles to which a multiplicity of analyte-binding ligands is attached.
- the microspheroidal particles are immobilized to a glass surface.
- the multiplicity of ligands to be anchored to the microspheroidal particles can be designed to detect a specific array of analytes. For example, in a specific embodiment, an environmental sample is tested for the presence of one or more human pathogens of public health significance, e.g.
- the microspheres are coated with a library of nucleic acids derived from a number of different pathogens.
- the combinations of ligands for anchoring to the microspheroidal particles is not limited.
- the kit may also contain quantum dots.
- Environmental sample as used herein means a specimen of any material collected from an environmental source, such as air, water or soil.
- An “environmental source” as used herein relates to the natural environment, man-made environment or the extraterrestrial environment. Other samples include food samples.
- the WGM assay is useful for the food industry, environmental water testing, the agricultural industry, bio- terrorism testing and pharmacological testing.
- the particles may also be re-cycled for continual use and for high throughput screening.
- the changes to the WGM indicate the presence of an analyte. It is also possible to glean further information from changes in the relative intensities, line widths and wavelengths of the WGM peaks of a particular microsphere.
- Fluorophore-conjugated microspheroidal particles conjugated to a multiplicity of DNA ligands demonstrated a measurable and consistent difference after binding of specific analyte.
- Microspheroidal particles either 4.87, 5.6, 6.8, or 7.5 ⁇ m in diameter were conjugated to a multiplicity of 22-mer DNA molecules with a TMR tag at nucleotide position 1.
- WGMs were acquired before and after hybridization with complementary 22-mer ( Figure 1).
- FIG. 2 provides a schematic illustration of the WGM detection system.
- the power of the light source was varied to determine its effect on WGM resolution.
- An incident power for the light source (532 nm, 200 milliseconds) of 6.3, 50.2, 214.5 or 1160.5 ⁇ W was sufficient to resolve WGMs (Figure 3B).
- Such power is achievable with a standard low cost laser (light pointer).
- the excitation time was varied in order to determine its effect on WGMs.
- WGMs were assessed following exposure for 10, 60, 200 and 1000 milliseconds of incident light (50 ⁇ W, 532 nm). It was determined that an exposure time as short as 200 ms was sufficient to resolve WGMs (Figure 4C) with visibility decreasing up to 5 seconds exposure time (Figure 4E).
- the prototype WGM biosensor is built to specifications that result in well-resolved WGM spectra before and after binding of an analyte to a microspheroidal particle.
- the device is approximately 30 x 15 x 15 cm and 2-5 kg, and is completely self-contained comprising a power source, light source, sample handling chambers and spectrophotometer.
- Microspheroidal particles (QSand [trademark: silica particles]) were immobilized to the surface of a glass microscope slide coverslip in a random configuration ( Figure 5). The coverslip with immobilized QSand (trademark) particles was able to be coupled directly into the slit of the spectrometer.
- WGM whispering gallery modes
- Succinimidyl ester dye-label tetramethyl rhodamine (TMR), Bodipy 630/650 and Alexa 647 was purchased from Olecular Probes, Eugene, USA. Milli-Q grade (R > 18 M ⁇ cm) water was used throughout. Acryloyl modified oligonucleotides were designed in-house and constructed by Integrated DNA Technologies, Coralville, Iowa, USA. The oligonucleotide constructs were received dry and resuspended to 200 ⁇ M with ultra-purified Milli-Q H 2 O before use.
- the spectral resolution (+ 0.9 nm) defines the accuracy with which a fluorescence peak wavelength can be measured. Peak shifts in a WGM response curve can be routinely observed between 0.1 nm up to several run. The optical resolution stated by the manufacturer indicates peaks with 0.14 nm - 7.7 nm FWHM can be routinely detected.
- microspheres were also collected using a Philips XL-30 field- emission SEM. To do this, microspheres were washed with Milli-Q H 2 O and immobilized directly onto 12 mm circular silica substrates, which were then mounted onto SEM studs. The samples were sputter coated with 3-5 nm of gold using an Edwards S 150B Sputter Coater.
- Oligonucleotide fragment design and construction [0154] The following single-stranded target and complementary oligonucleotide sequences were randomly designed and named for the sole purpose of this investigation; therefore homologies to known gene sequences are coincidental and should be disregarded. Designed sequences were synthesized and ordered from integrated DNA technologies, Coralville, Iowa, USA. The oligonucleotides were maintained as 200 ⁇ M working stocks in ultra-pure Milli-Q H 2 O.
- the oligonucleotide sequences and the shorthand names used throughout this Example are provided below.
- the modification "iAm” provides a free internal amine group (e.g. used to attach fluorophores) on the DNA fragment which essentially is a T nucleotide base with the free -NH group attached.
- AAT CCG CAG GAT GGG CCT TAC A - 3 1 (SEQ ID NO:6) [0156]
- the sequence /Acrd/ denotes a 5'acryloyl group (Acrydite-trademark, Integrated DNA Technologies, USA) group attached to the oligonucleotide sequences and /iAm/ specifies the position of a modified T nucleotide base which possesses a free internal amine group used for fluorophore attachment (Integrated DNA Technologies, USA).
- Microsphere surface functionalization [0157] The silica microspheres used in this investigation were functionalized with thiol groups using standard literature procedures (Battersby et al, Chemical Communications 74:1435-1441, 2002; Corrie et al, Langmuir 22 (6) :2731-27 '37, 2006; Miller et al, Chemical Communications 35:4783-4785, 2005; Johnston et al, Chemical Communications 7:848- 850, 2005; Verhaegh and Vanblaaderen, Langmuir 70f5j:1427-1438, 1994).
- Functionalized spheres were washed at 1800 rpm with 2-propanol and resuspended in 10 mL of fresh 2-propanol. This microsphere slurry was divided into aliquots and pelleted at 8000 rpm for 5 s and dried in a desiccator under nitrogen for 230 min. Finally, they were agitated and heat cured to ensure complete 2-propanol evaporation (9O 0 C) for 30 min on a heating block. All functionalized microspheres were stored desiccated at 4 0 C under nitrogen. The above procedure leads to reproducible, dense functionalization of the silica surface, and further ensures quantitative repeptization of the microspheres after storage. Surface layered nanocrystal doped microsphere synthesis
- CdSe@ZnS nanocrystal core/shells were used which emitted orange with emission maximum 593 nm; FWHM 32 run. Aliquots were taken from a 10 ⁇ M stock solution. MPS functionalized silica beads were combined with CdSe@ZnS core shell nonocrystals in a 1 :2.5 ratio, manually shaken, then put onto a rotator at minimum rpm for 15 min - 1 hr.
- the polar amide group within the pyrrolidone ring on the PVP molecule most probably facilitates chemisorption to the nanocrystal surface via covalent bonds.
- the coating offers stability to the microsphere (hydrophobicity and stability in water) and allows the molecule to be absorbed onto many surfaces. This increases the affinity of the particle to the final silica shell coating without the employment of a coupling agent. The following day reacted particles were washed several times (8000 rpm; 5 s) in 2-propanol and maintained 4 0 C in 2-fresh propanol.
- microspheres were capped in a 1 :200 solution of TEOS, 1 mL of 4.2% (in H 2 O) NH 3 solution was utilized per 1 mL of PVP capped particles in reaction and 1 :200 TEOS volume (100 ⁇ L per 0.005 g of PVP capped microspheres).
- TEOS was added under stirring and allowed to react overnight followed by several washes in 2-propanol.
- AU microspheres were kept suspended in 2-propanol and maintained at 4 0 C.
- the preparation was treated with a mixture of 58 ⁇ L Milli-Q H 2 O, 10 ⁇ L NaOAc, and 200 ⁇ L of ethanol, which were added directly to the reaction and the solution was then stored in a -2O 0 C freezer for 30 min. Samples were then centrifuged for 20 min at 13,800 rpm and the supernatant removed. These steps were repeated until the sample supernatant was free of excess fluorophore. Finally, the labeled oligonucleotides were diluted to a 200 ⁇ M working stock with 100 ⁇ L of ultra-pure Milli-Q H 2 O and stored in a -2O 0 C freezer.
- ⁇ cryloyl oligonucleotide coupling to microspheres [0160] Thiol functionalized microspheres were derivatized with enl and Control target 5' acryloyl modified oligonucleotides using standard protocols (Hermanson, Bioconjugative Techniques, Sand Diego: Academic Press Incorporated, 785, 1996) as follows: In an eppendorf tube 0.002 g of functionalized MPS microspheres were weighted out and then saturated with 100 ⁇ L of methanol via microcentrifugation (8000 rpm for 5 s), and the supernatant discarded.
- the pellet was resuspended in fresh 0.5 M MES (pH 5.4), followed by the addition of 15 ⁇ L of 200 ⁇ M acryloyl-modified TMR-labeled oligo-sequence (enl or Control) along with 100 ⁇ L fresh 10% w/v ammonium persulfate (w/v).
- the reaction was vortexed and then gently mixed on a motorized wheel for 1 hour.
- the coupled microspheres were washed with Phosphate Buffer Saline (Buffer) [ph 9.0] and pelleted in a microcentrifuge (8000 rpm for 5 s) to remove the supernatant.
- a sample of 200 ⁇ M stock cDNA solution was diluted with PBS (1:40), and the sample was vortexed. A 120 ⁇ L aliquot was applied to each array plate (enough to completely immerse the gridded array area). Each particle-mounted array then underwent 90 s single hybridization cycle.
- each grid was treated with 120 ⁇ L of the control solutions: Milli-Q H 2 O followed by buffer (PBS), non-specific DNA and cDNA (as above) and a hybridization cycle of 90 s was run for each treatment plate. All arrays were allowed to stand at RT for 5 min then gently washed with 100 ⁇ L portions of Milli-Q H 2 O to remove any solution phase (unreacted) DNA. Unless otherwise noted, excess water in all assays post cDNA treatment was removed by evaporation on a heating block (9O 0 C). The fluorescence excitation and emission signal measurements from treated spheres were then captured in air.
- Hybridization was carried out as above and then denaturation was effected by heating the hybridized samples on a 9O 0 C heating block for 30 s.
- the buffer was immediately removed by several 100 ⁇ L washes with Milli-Q H 2 O.
- the denaturation steps were repeated three times, followed by the evaporation of excess liquid and finally the measurement of emission from selected particles.
- the initial goal of this Example involved the surface functionalization of silica microspheres ( ⁇ 10 ⁇ m) with CdSe core shells (emitter) to enable a WGM signal to be created via ultraviolet (UV) illumination (Gomez et al, Small l(2):23S-24l, 2005).
- the NC particles were then capped with several organic stabilizing layers and the final functional layer was intended to be with a selected bio-molecule.
- the stability of the nanocrystals utilized in the experiments was compromised; progressive treatments led to consistent photodegradation and a loss of discernable WGM peaks before any possible conjugation with a biological molecule could be performed. The significant loss of photoluminescence was probably due to the desorption/break down of the nanocrystal layer.
- Every single functionalized microsphere exhibits a unique WGM fingerprint. Consequently, it is necessary for bioassays to be carried out on the same particles before and after exposure to a test solution.
- the particles were immobilized onto a gridded-silica array and a detailed microsphere map of the e «/-target and Control assay grids was collected.
- Each microsphere was numbered according to the other of its emission signal being measured; its specific location was then mapped out using the corresponding scan-number which was noted on a graphical schematic that represented a single etched grid.
- the same microsphere could be routinely relocated after exposure to various test solutions and controls.
- the refractive index of the microspheres is quite low and it was difficult to obtain high-quality WGM spectra from microspheres immersed in solution due to the low refractive index contrast. This was a fundamental problem and unexpected.
- the refractive index mismatch between colloidal silica and water is insufficient to support a WGM. Consequently, the protocols were designed so that all spectra could be collected in air.
- the array plates were treated with a 120 ⁇ L does of the target complement a-enl.
- the initial hybridization step involved the assay grids being placed on a 9O 0 C heating block; by slowly heating the solution, any oligomeric or aggregated DNA that is present in the target solution is peptized to facilitate hybridization with the probe DNA on the bead.
- the acryloyl/sulfhydryl bond formed when probe oligonucleotide was conjugated to the microspheres surface effectively tethered and immobilized the target-probe sequence to the spheres surface and was not effected by subsequent heating 9O 0 C.
- the arrays were cooled for 5 min at RT to allow sufficient time for the a-enl cDNA probes to anneal to enl target microspheres.
- the grids were then washed and all excess water was removed by evaporation on a heater block.
- Following treatment with the a-enl probe the same individual particles were relocated and a second set of spectra were collected in air.
- a fluorescence spectrum of the dye-label TMR employed to label enl and control oligonucleotide target sequences was fluorometrically analyzed.
- the emission range of the dye demonstrated the expected range of the microsphere emission signal which should be defined by the emission range of the selected fluorophore.
- the WGM emission signal falls within the excitation range of the TMR dye.
- the WGM spectra show a clear red-shift, though not every peak shifts equally.
- the peak displacements observed post cDNA a-enl hybridization measured at wavelengths 575 (1.1 nm), 585 (1.5 nm), 595 (1.1 nm) and 605 nm (1.1 nm) are all to longer wavelengths compared to the pre- hybridization emission signal, i.e. hybridization lead to red-shifts of the major peaks in the WGM spectrum.
- a control assay was then established to investigate the effects of control reagents on gallery mode signal.
- a single assay plate was treated with Milli-Q H 2 O, a non-specific DNA sequence and finally the cDNA probe.
- a 90 s hybridization cycle was run for each stage treatment, the selected spheres were relocated and the fluorescence spectra collected after each stage.
- Milli-Q and non-specific DNA treatment there was no consistent peak shift observed.
- red-shifts were observed when the microsphere was exposed to cDNA (a-enl).
- Example 5 showed that single silica colloids functionalized with single-strand oligonucleotide fragments and can delineate between differences of 10 nucleotide bases of a cDNA target probe.
- the results demonstrate that the WGM based system is capable of rapid, target-specific detection of complementary DNA fragments at room temperature (RT), at sub-picomolar concentrations and within just a few minutes using samples of several microlitres. The results indicate that attomole detection of unlabeled DNA fragments is possible on a routine basis.
- Particles were excited through a Melles Griot X2 multi-line Ar+ laser (Melles Griot, USA) typically at an excitation power of 350 ⁇ W.
- Emission signals were typically collected with the wavelength centre point at 600 nm through a 550 nm cut-off filter with a 2 s integration time.
- a 'real' assay environment is one in which functionalized particles are exposed to various control reagents, specific and non-specific unlabeled analyte and hybridization buffers under various reaction conditions as prescribed in Example 5.
- a competitive detection platform in the current market should be able to routinely detect sub-picomolar concentrations of analyte.
- This Example investigates whether the WGM assay can be performed at room temperature and the detection limit of the system presented in Example 5 is determined. Unless otherwise stated, the assays performed in this Example were as prescribed in Example 5.
- the array-plates were washed with Milli-Q H 2 O to dilute the saline reaction buffer, and ensure that when excess reactant was evaporated off that salt-crystal deposition on the assay plate was minimized. Particles were then recovered and the relevant 'post-hybridization' emission signals measured.
- the arrays were then run for a single hybridization cycle of either 10 s, 30 s, 60 s, 180 s or 300 s at RT.
- Post-treatment array-plates were allowed to stand for 5 min at RT, washed with Milli-Q H 2 O and dried. Sensors were then recovered and the relevant emission signals measured.
- Gallery mode signatures were acquired from 7.50 ⁇ m silica particles functionalized with TMR labeled 70 base-oligonucleotide fragments using two characterization set ups. The first a TE2000-S Nikon fluorescence microscope coupled to an ocean optics CCD ( ⁇ 0.9 run ) detector ( Figure 8A) and higher resolution spectra were acquired using an Olympus Fluoview laser Scanning Microscope 1X71 (Olympus, USA) coupled to a TRIAX spectrometer ( ⁇ 0.05 nm) Figure 8B. The key feature of the developed recognition platform is the 'single-particle' method utilized for particle scoring.
- Figure 8C illustrates the fundamental reason for the chosen format and why it is crucial in a WGM based system.
- the key point to take from the schematic is that to use the optical properties of WGM in a detection platform, averaging spectra from ensemble results can not be performed successfully as the example shows two identically modified particles, from the same sample have unique emission signatures.
- a single particle acts as its 'own-reference', thus a single particle can be seen as a single experiment.
- This parameter formed the fundamental analytical variable in the developed hybridization assay.
- the spectral resolution of the CCD set-up generally employed in this investigation could limit the sensitivity of the WGM sensors.
- the sensitivity depends critically on the spectral resolution of the detector employed.
- the Ocean Optics detector has a resolution of 0.9 nm, and the WGM emission peaks are damped due to the low spectral resolution. Hence, there is no information that can be gleaned from the mode shapes. Nevertheless, these simple spectrometers enable the assay to be carried out cheaply and could be done in the field routinely.
- Hybridization induced red-shifts are routinely observed with 70 base-oligo- modified particles treated with sub-picomolar cDNA concentrations from a 120 ⁇ L dosage volume.
- Benchtop, LN2-cooled CCDs and grating monochromators are necessary to properly observe and characterize the WGM modes of the microspheres, but for assay purposes such high resolution is not a pre-requisite.
- At the lowest DNA concentrations one can observe small, random blue- shifts from post hybridized particles. These indicate that the WGM emission can be influenced by small perturbations such as minute changes in the solution refractive index due to temperature fluctuations and electrolyte concentration. This determines the ultimate practical limit in sensitivity possible for these bioassays in aqueous media. Consequently, only consistent red-shifts of four or more peaks are taken to indicate a positive detection event.
- a disadvantage of silica-based WGM platform is it cannot be used entirely in solution.
- the limitations associated with the current WGM system are alleviated by designing a conjugation protocol along with the development of a highly- sensitive, whispering gallery mode (WGM) solution based genotyping system.
- the system comprises a uniform, highly-cross linked melamine formaldehyde microsphere ( ⁇ 7.52 ⁇ m) functionalized with a fmorophore and a monolayer of single-strand oligonucleotides.
- Using a microplate-well system an assay can be completed entirely in solution.
- the WGM label-free system can score polymorphic amplified DNA targets at sub-picomolar sensitivity.
- the frequency shifts detected in water can be used to monitor the denaturation of the double-stranded post-hybridization complex at elevated temperatures. Controlled by a two-step temperature gradient the optical switching capability of the polymer based sensor is also demonstrated as the WGM shifts can be reversed and re-activated routinely.
- biocompatible melamine composite particles are commercially available in a wide range of particle sizes (300 nm - 12 ⁇ m).
- the material's high refractive index (n r 1.68) which is greater than that of polymethylmethacrylate (n r 1.48), silica and most other glass materials (n t 1.47 - 1.50) offers a clear advantage.
- the increased refractive index mismatch between an MF particle and an external water-medium (n r 1.33) should improve the quality factor of the WGMs.
- the mismatch is large enough that it enables simplified assays to be carried out in solution.
- This Example examines the development of a single particle, label-free WGM 'wet-assay' for oligomeric target detection.
- the particles possess Q factors similar to those of silica microspheres of the same size in air.
- the assay can routinely detect sub-picomolar levels of unlabeled oligonucleotide fragments in solution in a micro-well plate bench-top format.
- the findings presented show that fluorescent WGM signals in highly cross-linked melamine formaldehyde (MF) microspheres ( ⁇ 10 ⁇ m) positively discriminate a single nucleotide polymorphism (SNP) between unlabeled PCR amplified fragments of genomic DNA (gDNA) of three individuals carrying a different nucleotide at a particular loci.
- MF melamine formaldehyde
- SNP single nucleotide polymorphism
- a microscope PElOO-NI system inverted peltier stage was utilized for thermocycling hybridization studies.
- the system comprised a diaphot range of inverted scopes with XY table customized for a Nikon TE200/300 microscope table.
- the stage temperature range (- 5 to 99 0 C) was controlled with a PElOO-I heating/cooling peltier stage.
- the stage was coupled to a water circulation pump to regulate stage temperature.
- GAA - 3' SEQ ID NO:8
- T a- rs 10434 B (mismatch) 5'- CAG GAG [C]CC AC/iAm/ GGC AGA TGT CCC GGC
- PCR amplified regions of gDNA containing the rs 10434 SNP labeled Individual 1 [A/ A]; Individual 2 [A/G]; Individual 3 [G/G] were provided by the International Diabetes Institute (Melbourne, Australia). Genotyping was carried out using the Mass ARRAY system (Sequenom, San Diego, CA), as previously described (Peyrefitte et al, Mechanisms of Development 104(l-2):99- ⁇ 04, 2001). Briefly, PCR primers were designed for rslO434 using SpectroDESIGNER to amplify a 97 bp fragment surrounding the variant site.
- Reactions were performed using 2.5 ng genomic DNA, 2.5 mmol/L MgCl 2 , standard concentrations of other PCR reagents and 0.1 unit HotStar Taq DNA polymerase (Qiagen, Germany) in a total reaction volume of 5 ⁇ L. Fragments were isolated by electrophoresis using Qiaquick gel extraction kit (Qiagen, Germany) as per the manufacturer's instructions.
- Aery loy I mediated conjugation of oligonucleotide fragments to microspheres [0191]
- the raw melamine particles were washed several times in Milli-Q (8000 rpm for 5 s) and stored dry and desiccated at 4 0 C under nitrogen. Washed MF particles (2 mg) were weighed in an eppendorf tube.
- the native surface chemistry of the melamine particles (Gao et al, Macromolecular Materials and Engineering 286(6):355-361, 2001) provided a robust conjugation surface to immobilize the single-strand oligonucleotide fragments.
- Microspheres were initially diluted in a series of four dilutions by taking 1 ⁇ L stock microspheres (2 mg / 1 mL) and resuspending it in 1 mL of Milli-Q (dilution 1) and vortexing. Then 250 ⁇ L of the dilution was resuspended in 1 mL of Milli-Q H 2 O and vortexed. This process was repeated with the new dilution three times. A 1 ⁇ L aliquot from dilution 3 or 4 would typically contain 1 particle / ⁇ L.
- the heating stage temperature was increased to 37 0 C and allowed to equilibrate for 2 min and then a single spectrum was captured. 5 ⁇ L of Milli-Q or a 2 ⁇ M target probe solution was then applied to the well. The stage-temperature was increased to 72 0 C and held for 2 min followed by spectral acquisition. Finally the stage temperature was decreased to 37 0 C or room temperature.
- oligonucleotide fragments used to functionalise the microspheres were designed and constructed to mimic a 30 base strand spanning the rs 10434 SNP region of the human genome. The sequence is homologous to the region on chromosome 6.
- VEGF vascular endothelial growth factor receptor
- the hyperglycaemia experienced by diabetic patients causes abnormal vascular cell function, in particular in the endothelium at later stages of the disease. These individuals commonly experience progressive degeneration of the micro- and macro-circulation which consequently leads to organ damage (Laselva et al, Acta Diabetologica 30( ⁇ :190-200, 1993; Ciulla et al, Acta Ophthalmologica Scandinavica 80(5) ⁇ 68-477, 2002). Studies have demonstrated that the selected SNP region could potentially be used as a marker for T2D and related illnesses. The findings presented here demonstrate the validity of the optimized WGM platform as an effective diagnostic tool to routinely score known human disease related SNP targets.
- the oligo-modified MF particles have a diameter of 7.52 microns and were directly bioconjugated with 5' acryloyl modified TMR labeled target oligonucleotides.
- MF particles ability to support a WGM in solution led to the next investigation, which was to select a hybridization substrate which facilitates routine acquisition of relatively high-Q WGMs in solution.
- Presenting the particles in a micro-titre plate format moves a step closer towards the direction of a high throughput automated assay.
- the analysis was based on WGM signal quality that could be collected from the oligo-modified MF particles while immobilized on a micro-well and assay plate substrate.
- Modified MF particles were immobilized on a silica gridded array plate, within a single well 384 well polycarbonate cytoplate, 384 well optical plate and a 96 well polymer cell culture plate. Emission signals were collected from selected particles while immersed in standard hybridization buffer.
- Figure 12 illustrates a representative emission profile obtained using each selected substrate. Due to the small working width of the substrate it was expected that the silica gridded array would produce high signal outputs from a selected MF particle ( Figure 12A). However for a high throughput format, a well-based system was the desired direction. The first micro-plate system analysis was carried out with a common plastic based 96 well culture plate ( Figure 12B). The collected emission signal indicates a WGM profile consisting of several broad low intensity peaks. This was simply due to a large width of the base of each well and to the fact that plastic has high scattering properties. Also the use of a lower objective magnification power (x 40) to allow for a large working distance reduced the overall signal.
- x 40 objective magnification power
- Each well had a smaller total working volume (polymer based plate: base width 100 ⁇ m; well area, 0.05 cm 2 / well with a total working volume, 120 ⁇ L / well). Also the flat bottom well geometry and visible transparency allowed easy access to the plate and manipulation using the microscope X/Y oriented working stage.
- Figure 12C shows an example of a typical emission signal from an MF particle. Present are a series of identifiable narrow, high intensity fluorescent peaks. A 384 optical plate was also employed with the same working dimensions and volumes as the polymer plate. However, the base width was narrower (50 ⁇ m) and the well base did not hold a positive charge. Nine distinct emission peaks are noted within the WGM profile as indicated in Figures 13 A and C.
- the reference photoluminescence (PL) signal was measured from selected particles and the plate was heated to standard hybridization assay temperature (9O 0 C). The temperature was maintained for three hours during which time the selected particles were relocated and the emission signal regularly collected.
- Figure 14 presents normalized WGM spectra acquired from the selected particles after 3 hours of heat exposure. Over the 3 hr period the greatest effect was noted in the particle immersed in MES (black dashed line) which exhibited a significant loss of PL signal compared with particles immersed in hybridization buffer (black solid line). The strongest signal following heat treatment was observed in the control particle which was maintained in Milli-Q only (grey solid line). The emission signal level did vary between samples. However, a clear WGM profile with several identifiable peaks could still be obtained from each particle after 3 hrs heating.
- a single 7.52 ⁇ m MF-rslO434 target particle was cycled through a two-step gradient (37°C-72°C).
- An initial hybridization reaction was completed following the addition of 5 ⁇ L of Milli-Q.
- Spectra acquired at a 2 s integration time at each gradient temperature through several cycles indicated no consistent movement of the WGM peaks Figure 15A-B.
- the experimental conditions were repeated with addition of the target probe DNA (5 ⁇ L of a 2 ⁇ M stock).
- DNA fragments of approximately 20 bases were amplified using primers which spanned the rs 10434 SNP region.
- the genotypes of the above individuals were determined using the Sequenom Mass ARRAY genotyping platform. Each individual had a different genotype. Individual 1 was homozygous for the A allele (A/A), individual 2 was heterozygous (AlG) and individual 3 was homozygous for the G allele (G/G) at this locus.
- the aim here was to determine whether a single base pair difference could be detected from the PCR amplified samples using the WGM system.
- a single rslO434-MF particle specific for the A allele of the rs 10434 DNA variant was immobilized in a micro-plate well; the particle was then exposed to the 3 different analytes over separate hybridization reactions. Each hybridization was completed at 90 0 C for 5 min after a 2 ⁇ L addition of the DNA sample (Individual 1-3). Emission signals were collected after each hybridization reaction respectively after the reaction temperature gradient had been decreased to ambient room temperature. WGM signatures acquired after each treatment relative to the reference signal (black spectra) were determined. The peak positions were analyzed relative to the un-treated WGM profile and the L ⁇ noted. The spectra obtained show the peak wavelength positions as a function of the peak-shift about the given reference wavelength.
- Exposure of a single particle to both target probes resulted in a blue shift of all major fluorescence gallery mode peaks post a- rs 10434 B treatment, if the particle was initially exposed to a- rs 10434 A target fragments.
- the native surface of the MF particles facilitates conjugation of a dense monolayer of acryloyl modified oligonucleotide fragments.
- the conjugation is essentially the covalent linkage of a melamine molecule with an acrylic acid.
- the oligonucleotide modified particles are highly resilient when exposed to high pH solutions at elevated temperatures (90 0 C) as high quality WGM signals can be collected from the particles after prolonged exposure. Data demonstrate that FITC labeled human ⁇ -IgM antibodies can also bind effectively to the un-modified MF particles. These particles can then be utilized in antibody-antigen binding assays.
- DNA has a higher refractive index in the single-stranded (denatured) conformation (Parthasarathy et al, Applied Physics Letters 87(11) ⁇ 13901-3, 2005). In its native form the refractive index of DNA is similar to that of typical organic polymers (Samoc et al, Chemical Physics Letters 431(1-3):U2-134, 2006). Naturally double-stranded DNA exists as a dielectric material, and alternatively in the denatured form it becomes a semiconductor with a band gap of a few hundred milli-electronvolts (Rakitin et al, Physical Review Letters 86(16):3670, 2001).
- the WGM shifts described in this Example are governed by a decrease or increase in the relative refractive index at the microsphere surface in direct association with an increase in the microspheres diameter (Niu and Saraf, Smart Materials and Structures 11(5):778-7S2, 2002). How these parameter(s) influence the WGM specifically is yet to be elucidated, however in contrast the characteristic shifts are routinely reproducible using both composite particles.
- the position of the fluorophore at the first nucleotide base of the tethered acryloyl oligonucleotides facilitates the routine total-internal-reflection of the excited light in air and water mediums.
- the system described in the current Example does not utilize optic- fibre coupling methods to excite a WGM which drastically simplifies the assay. Attomole volumes of target DNA probe solution can be routinely detected. The cyclically reversible WGM shifts observed in the MF microspheres importantly indicates the particles can be recycled. The WGM peak shifts were shown to be reversible when the local temperature was oscillated above and below the T m of the target probe; hence, the spectral red-shifts are specifically due to hybridization of complementary DNA. The binding affinity of a target probe is significantly decreased when a DNA fragment has a single base mismatch.
- Nonspecific binding although found to be negligible can cause small blue-shifts in a particle's WGM spectra if the same particle is initially exposed to a complementary target.
- the compared WGM emission spectra indicate a specific target probe has a far greater binding affinity as opposed to a fragment containing a single base mismatch.
- This Example reports on the development of a series of optimized parameters to routinely excite high quality whispering gallery modes (WGM) in the fluorescent colloids.
- WGM whispering gallery modes
- TSOM target specific oligonucleotide-modif ⁇ ed silica and melamine microspheres (7.50 - 7.52 ⁇ m) [Microparticles Germany GmbH] presented in Examples 5 to 7 are utilized throughout.
- Coupling position effects [0215] Using the confocal set-up, an angle-resolved spectroscopic technique was designed to characterize the WGM emission as a result of altering the laser excitation position. Cover glass array slides were prepared with TSOM silica and MF particles as prescribed previously (Examples 5 to 7). The confocal system employed was utilized to alter the excitation position around the circumference of the particle using the acquired particles' transmission image as a reference. At a 350 ⁇ W radiation power selected particles were excited through a multi-line Ar+ laser. The emission spectra were collected at a 2 s integration time. For all confocal work herein an Ar+ laser was used for particle excitation.
- the excitation position was altered at 45° increments over a 360° rotation around the microspheres peripheral boundary relative to the 0° (reference) co-ordinate.
- a particle's WGM is excited on the confocal set-up the excitation position 0° is normally utilized, this results in the routine acquisition of high quality WGMs.
- excitation at the selected positions through 360° also results in the collection of strong WGM spectra.
- Analysis of the spectra-set for the selected example demonstrates no detectable peak shifts are observed for the selected excitation positions (within the spectral resolution of the Triax 550 spectrometer ⁇ 0.05 nm). In some cases a peak distortion can occur. The distortion was consistently observed in each WGM spectra acquired at the given wavelength.
- a selected MF particle was then scanned in air under the same conditions. Analysis of the WGM spectra-set demonstrates that relative to the 0° spectra, detectable peak shifts are observed (spectral resolution of the CCD ⁇ 0.05 nm. Blue shifts are observed in the selected example, however, it is unlikely the particles refractive index has changed to cause the observed shifts. These effects could be due to the movement of the excitation position but are more likely the result of reaching the threshold limits of the CCD. The total internal reflection of light through a TSOM-MF particle immobilized in solution was demonstrated in Example 7. A single MF particle immersed in solution was then excited at the selected radial positions.
- the particles were immobilized on cover glass arrays, the substrates were then mounted on a confocal microscope. Selected silica and MF microspheres were excited in air through the 0° excitation position (integration time 2 s). Spectra set acquired at a 2 s integration time from the selected silica microsphere. The WGM photointensity (PI) significantly decreases in fluorescence intensity after the series of scans. Ten distinct peaks were identified in Scan 1 and 9-10 peaks from the Scan 20.
- the next step was to repeatedly excite a single TSOM MF particle in solution (Milli-Q H 2 O).
- a single particle was lased at position 0° and set of spectra were captured at a 2 s integration time.
- the number of identified peaks decreased within the selected scan range (eight) in comparison with the air measurements. However, the peak number remained unchanged after the scans were complete (scan 1-20). A six-fold decrease in the Q-factor is observed between scan 1 and 20, respectively.
- the sensitivity of a spectrometer has an important role in WGM measurements during a working assay.
- the spectrometer determines the amount of spectral information one can acquire from an excited particle and the sensitivity limits of the WGM detection platform.
- microscope set-ups and sensitivity of the CCD detectors are compared.
- a silica particle was first excited (position 0°) in air, and the spectra collected with a Triax 550 spectrometer (spectral resolution ⁇ 0.05 nm) at an integration time of 2 s. A spectrum was then acquired from the same particle through a mercury lamp (excitation output power 35.52 mW). A QE6500 Ocean Optics system (spectral resolution ⁇ 0.9 nm) at an 2 s integration time was utilized to acquire a spectrum. A clear broadening is observed of several major peaks from the spectra acquired with the QE6500 spectrometer.
- the spectra acquired through the Triax 550 indicates several peaks ( ⁇ nax - 577.54 nm, 588.47 nm, 594.35 nm and 599.95 nm) are not present in the QE6500 spectra.
- the spectrum acquired through the Triax 550 indicates a loss of several peaks results when the QE6500 is utilized for WGM acquisition 578.81 nm, 584.65 nm, 588.07 nm, 597.73 nm and 608.08 nm).
- the FWHM values Triax (0.72 nm) and QE6500 (1.27 nm) further indicate the difference in spectral quality.
- the WGM peak shift between spectrometers is simply due to the differing sensitivity of the spectrometers.
- the spectral resolution of the instrument defines the accuracy in which a peak position can be measured as a 'true' ⁇ nax -
- the Ocean Optics system ( ⁇ 0.9 nm) is less accurate in relation to the 'true I max ' for each observed WGM peak compared with the TRIAX system ( ⁇ 0.05 nm). Therefore based on these conditions it is expected that there will be variability between the WGM response curves.
- a bleaching threshold of the microspheres was determined while under constant excitation through a fixed coupling position.
- Figures 17(A) and (B) show a comparison of the WGM profile obtained using silica particles (B) and melamine formaldehyde particles (A).
- the solid lines in (A) and (B) were the profiles obtained in air and the dotted lines represent the profiles when the particles were in aqueous media.
- An immuno-based WGM assay provides a setting for a diagnostic platform. Data demonstrate a fluorescent WGM signal entitled from an antibody (Human ⁇ -IgM) modified MF particle can be utilized to discriminate between a control reagent and target antigen ( Figure 17) in a room temperature reaction.
- the immuno-WGM assay provides an alternative recognition format with tunable specificity to a plethora of biomolecular targets such as proteins, antibodies, animal and plant pathogens, bacteria, interleukins, peptides, RNA, niRNA and prions. Immuno-WGM assay has potential in applications in the food hygiene industry, environmental water testing, agricultural industry, military (biowarfare), virology, microbiology diagnostics and pharmacological screening.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nanotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2009317878A AU2009317878B2 (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay |
JP2011536705A JP5588454B2 (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay |
CA2744331A CA2744331C (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay based on fluorescently labelled microspheroidal particles |
EP20090827053 EP2368115B1 (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay |
MX2011005366A MX2011005366A (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay. |
CN200980153782.XA CN102272597B (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay |
US13/130,566 US8617824B2 (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay |
ES09827053.1T ES2545232T3 (en) | 2008-11-21 | 2009-11-20 | Analyte Detection Assay |
BRPI0921591A BRPI0921591A2 (en) | 2008-11-21 | 2009-11-20 | methods of detecting analyte in a medium and event of binding between analyte and ligand and their uses |
NZ592953A NZ592953A (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay using melamine formaldehyde |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2008906057A AU2008906057A0 (en) | 2008-11-21 | Analyte detection assay | |
AU2008906057 | 2008-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010057264A1 true WO2010057264A1 (en) | 2010-05-27 |
Family
ID=42197758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU2009/001515 WO2010057264A1 (en) | 2008-11-21 | 2009-11-20 | Analyte detection assay |
Country Status (11)
Country | Link |
---|---|
US (1) | US8617824B2 (en) |
EP (1) | EP2368115B1 (en) |
JP (1) | JP5588454B2 (en) |
CN (1) | CN102272597B (en) |
AU (1) | AU2009317878B2 (en) |
BR (1) | BRPI0921591A2 (en) |
CA (1) | CA2744331C (en) |
ES (1) | ES2545232T3 (en) |
MX (1) | MX2011005366A (en) |
NZ (2) | NZ597114A (en) |
WO (1) | WO2010057264A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019043277A1 (en) | 2017-08-31 | 2019-03-07 | Medina Venegas Pedro Manuel | Method and device for analysing nucleic acids |
WO2024182168A1 (en) * | 2023-02-28 | 2024-09-06 | The Regents Of The University Of California | Biosensor materials |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011077838A1 (en) * | 2009-12-25 | 2011-06-30 | コニカミノルタエムジー株式会社 | Silica nanoparticles having fluorescent substance confined therein, and labeling agent for biosubstance |
JP2014178151A (en) * | 2013-03-13 | 2014-09-25 | Nagasaki Prefecture | Microorganism detection method and device using microsphere resonance sensor |
US9486163B2 (en) | 2014-02-21 | 2016-11-08 | Verily Life Sciences Llc | Silicon-vacancy-doped nanodiamonds for molecular and cellular imaging |
US9435791B2 (en) | 2014-06-27 | 2016-09-06 | Verily Life Sciences, LLC | Method for using nanodiamonds to detect nearby magnetic nanoparticles |
US9759719B1 (en) | 2014-07-21 | 2017-09-12 | Verily Life Sciences Llc | Nanodiamond counting |
US10103357B2 (en) | 2016-02-17 | 2018-10-16 | The Curators Of The University Of Missouri | Fabrication of multilayer nanograting structures |
CN110139828B (en) | 2016-08-25 | 2021-05-28 | 豪夫迈·罗氏有限公司 | Multifunctional silicon nanoparticles, method for the production thereof and use thereof in electrochemiluminescence-based detection methods |
DE102016221875B4 (en) * | 2016-11-08 | 2018-06-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Stationary phase for detecting a particular analyte in a mixture, uses thereof, and method for detecting a particular analyte in a mixture |
CN106814185B (en) * | 2017-01-11 | 2018-05-08 | 东南大学 | A kind of micro-fluidic detection chip based on Whispering-gallery-mode microcavity array |
KR102079721B1 (en) * | 2018-03-20 | 2020-02-20 | 성균관대학교산학협력단 | Optical probe based on thin-film interference |
CN108760704A (en) * | 2018-06-01 | 2018-11-06 | 北京工业大学 | A kind of unicellular interior substance detecting method based on Whispering-gallery-mode |
CN110747257A (en) * | 2019-10-31 | 2020-02-04 | 天津大学 | Method and kit for detecting miRNA based on one-step fluorescence cycle attenuation method for non-diagnosis purpose |
CN111999270A (en) * | 2020-06-10 | 2020-11-27 | 北京工业大学 | Exosome detection method based on whispering gallery mode optical microcavity |
CN113265249B (en) * | 2021-05-17 | 2023-08-04 | 重庆医科大学 | Preparation and biosensing application of functionalized hydrophilic lead halide perovskite quantum dot |
CN115414703B (en) * | 2022-11-03 | 2023-01-17 | 百力格生物科技(上海)股份有限公司 | Method for purifying nucleic acid probe modified by dye |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020097401A1 (en) * | 2000-08-08 | 2002-07-25 | Luftollah Maleki | Optical sensing based on whispering-gallery-mode microcavity |
WO2005116615A1 (en) | 2004-05-26 | 2005-12-08 | Genera Biosystems Pty Ltd | Biosensor using whispering gallery modes in microspheres |
US7259855B2 (en) * | 2003-10-14 | 2007-08-21 | 3M Innovative Properties Company | Porous microsphere resonators |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7384797B1 (en) * | 2000-10-12 | 2008-06-10 | University Of Utah Research Foundation | Resonant optical cavities for high-sensitivity high-throughput biological sensors and methods |
-
2009
- 2009-11-20 NZ NZ597114A patent/NZ597114A/en not_active IP Right Cessation
- 2009-11-20 EP EP20090827053 patent/EP2368115B1/en not_active Not-in-force
- 2009-11-20 AU AU2009317878A patent/AU2009317878B2/en not_active Ceased
- 2009-11-20 US US13/130,566 patent/US8617824B2/en not_active Expired - Fee Related
- 2009-11-20 ES ES09827053.1T patent/ES2545232T3/en active Active
- 2009-11-20 NZ NZ592953A patent/NZ592953A/en not_active IP Right Cessation
- 2009-11-20 BR BRPI0921591A patent/BRPI0921591A2/en not_active IP Right Cessation
- 2009-11-20 CN CN200980153782.XA patent/CN102272597B/en not_active Expired - Fee Related
- 2009-11-20 MX MX2011005366A patent/MX2011005366A/en active IP Right Grant
- 2009-11-20 JP JP2011536705A patent/JP5588454B2/en not_active Expired - Fee Related
- 2009-11-20 CA CA2744331A patent/CA2744331C/en not_active Expired - Fee Related
- 2009-11-20 WO PCT/AU2009/001515 patent/WO2010057264A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020097401A1 (en) * | 2000-08-08 | 2002-07-25 | Luftollah Maleki | Optical sensing based on whispering-gallery-mode microcavity |
US7259855B2 (en) * | 2003-10-14 | 2007-08-21 | 3M Innovative Properties Company | Porous microsphere resonators |
WO2005116615A1 (en) | 2004-05-26 | 2005-12-08 | Genera Biosystems Pty Ltd | Biosensor using whispering gallery modes in microspheres |
Non-Patent Citations (9)
Title |
---|
"Fluorescent Microparticles and Nanobeads", BIOFILES FOR LIFE SCIENCE RESEARCH, vol. 2, no. 5, 2007, pages 25 - 27, XP008166391, Retrieved from the Internet <URL:http://www.siemaaldrich.com/etc/medialib/docs/Sigma/GeneralInformation/2/biofilesissue10.Par.0001.File.tmp/biofilesissue10.pdf> [retrieved on 20100125] * |
D.E. GOMEZ ET AL.: "Tunable Whispering Gallery Mode Emission from Quantum-Dot Doped Microspheres", SMALL, vol. 1, no. 2, 2005, pages 238 - 241, XP002549921 * |
E. NUHUJI ET AL.: "Detection of Unlabeled Oligonucleotide Targets Using Whispering Gallery Modes in Single, Fluorescent Microspheres", SMALL, vol. 3, no. 8, 2007, pages 1408 - 1414, XP055032883 * |
ERICKSON ET AL., SCIENCE, vol. 249, 1990, pages 527 - 533 |
HODGSON, BIOLTECHNOLOGY, vol. 9, 1991, pages 19 - 21 |
MOLLER ET AL., APPLIED PHYSICS LETTERS, vol. 83, no. 13, 2003, pages 2686 - 2688 |
See also references of EP2368115A4 * |
WELLS, METHODS ENZYMOL., vol. 202, 1991, pages 2699 - 2705 |
Y.P. RAKOVICH ET AL.: "Raman scattering and anti-Stokes emission from a single spherical microcavity with a CdTe quantum dot monolayer", APPLIED PHYSICS LETTERS, vol. 83, no. 13, 29 September 2003 (2003-09-29), pages 2539 - 2541, XP002452682 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019043277A1 (en) | 2017-08-31 | 2019-03-07 | Medina Venegas Pedro Manuel | Method and device for analysing nucleic acids |
WO2024182168A1 (en) * | 2023-02-28 | 2024-09-06 | The Regents Of The University Of California | Biosensor materials |
Also Published As
Publication number | Publication date |
---|---|
CN102272597B (en) | 2014-05-07 |
CA2744331A1 (en) | 2010-05-27 |
ES2545232T3 (en) | 2015-09-09 |
AU2009317878B2 (en) | 2014-11-27 |
MX2011005366A (en) | 2011-11-04 |
JP2012509070A (en) | 2012-04-19 |
NZ597114A (en) | 2012-06-29 |
US8617824B2 (en) | 2013-12-31 |
EP2368115A1 (en) | 2011-09-28 |
US20110256528A1 (en) | 2011-10-20 |
CA2744331C (en) | 2017-04-04 |
EP2368115B1 (en) | 2015-05-13 |
CN102272597A (en) | 2011-12-07 |
NZ592953A (en) | 2012-10-26 |
JP5588454B2 (en) | 2014-09-10 |
EP2368115A4 (en) | 2012-08-22 |
BRPI0921591A2 (en) | 2019-09-24 |
AU2009317878A1 (en) | 2010-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009317878B2 (en) | Analyte detection assay | |
US9260656B2 (en) | Fluorescent silica nano-particle, fluorescent nano-material, and biochip and assay using the same | |
Cao et al. | Raman dye-labeled nanoparticle probes for proteins | |
EP2217928B1 (en) | Alternate labeling strategies for single molecule sequencing | |
Brouard et al. | Label-free biosensing based on multilayer fluorescent nanocomposites and a cationic polymeric transducer | |
EP1639370B1 (en) | Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes | |
Rousserie et al. | Semiconductor quantum dots for multiplexed bio-detection on solid-state microarrays | |
US20050250094A1 (en) | Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes | |
Yan et al. | High-throughput single-particle analysis of metal-enhanced fluorescence in free solution using Ag@ SiO2 core–shell nanoparticles | |
JP2005524849A (en) | Nanoparticle probes for analyte detection with fingerprints for Raman spectroscopy | |
WO2005043109A2 (en) | Sers diagnostic platforms, methods and systems including microarrays, biosensors and biochips | |
JP2006511792A (en) | Microporous material, analyte localization and quantification method, and analyte localization and quantification article | |
JP2012137490A (en) | Biosensor using whispering gallery modes in microspheres | |
JP2009540326A (en) | Increased specificity of analyte detection by measuring bound and unbound labels | |
Nuhiji et al. | Detection of unlabeled oligonucleotide targets using whispering gallery modes in single, fluorescent microspheres | |
EP2839284A1 (en) | A microparticle assembly | |
US20030013109A1 (en) | Hairpin sensors using quenchable fluorescing agents | |
CN105372421B (en) | Avian flu virus detection based on intelligent aqueous gel fluorescence aptamer sensor | |
Guo et al. | Photoswitch-based fluorescence encoding of microspheres in a limited spectral window for multiplexed detection | |
CN1484710A (en) | Bio-chip photoluminescent method for identifying biological material and apparatuses for use with such methods and bio-chips | |
Bake et al. | Multiplexed spectroscopic detections | |
De et al. | Diatoms as sensors and their applications | |
WO2007044025A9 (en) | Method for detecting analytes based on evanescent illumination and scatter-based detection of nonoparticle probe complexes | |
Verdoold et al. | Gold nanoparticle assays: towards single molecule unamplified DNA detection | |
JP2003156444A (en) | Simplified colorimetric assay for molecule using fluorescent sphere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980153782.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09827053 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009317878 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 592953 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011536705 Country of ref document: JP Ref document number: 2744331 Country of ref document: CA Ref document number: MX/A/2011/005366 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2009317878 Country of ref document: AU Date of ref document: 20091120 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009827053 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13130566 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0921591 Country of ref document: BR Kind code of ref document: A2 Effective date: 20110518 |